Cochrane Abstracts
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia:_Cochrane_systematic_review.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia:_Cochrane_systematic_review. Accessed January 17, 2025.
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia:_Cochrane_systematic_review
Naftopidil for the Treatment of Lower Urinary Tract Symptoms Compatible With Benign Prostatic Hyperplasia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia: Cochrane systematic review
ID - 433799
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433799/all/Naftopidil_for_the_treatment_of_lower_urinary_tract_symptoms_compatible_with_benign_prostatic_hyperplasia:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
